Since its foundation on May 29, 2000, Amicogen Biotech R&D Center has obtained patents being recognized its inventive steps and the novelty of the developmental technologies of the evolution of the molecular gene. Based on this, we focus on the development of various industrial specialty enzymes, including enzymes (CX), necessary for the production of Cepha antibiotics material (7-ACA) and we have the related patents.
By expanding the special enzyme technology, we carry out researches for getting domestic and overseas patents registration through the development of bio new materials (N-acetylglucosamine, D-chiro-inositol and pinitol, collagen peptide and collagen tripeptide, chitosan, citrine etc.) and resin for protein purification (Protein A-resin etc.).